Search results for "Highlights"

Results 161 - 170 of about 406 for "Highlights".
Sort by: Relevance | Newest | Oldest

Drug-eluting stents may not confer advantage in diabetic patients

An editorial noted that drug-eluting stents may work for noncomplex lesions in patients with diabetes, but complex disease states incurred high rates of myocardial infarction and revascularization.
11 Jan 2019

Consensus report updates evidence on managing hyperglycemia in patients with type 2 diabetes

The American Diabetes Association and the European Association for the Study of Diabetes updated their 2018 recommendations based on trials published in 2019.
10 Jan 2020

Cardiovascular event rates similar among newer second-line medications for type 2 diabetes

The comparison of dipeptidyl peptidase-4 inhibitors with other drug classes did find higher rates of major adverse cardiovascular events with basal insulin, sulfonylureas, and meglitinides than with the newer drugs.
11 Jan 2019

SGLT2 inhibitors associated with increased risk of amputations, diabetic ketoacidosis

Sodium-glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide-1 receptor agonists had similar rates of other adverse events, including bone fracture, acute kidney injury, serious urinary tract infection, venous thromboembolism, and acute pancreatitis.
14 Dec 2018

New equation with five variables helps predict hip fracture risk in type 2 diabetes

Age, sex, body mass index, peripheral sensory neuropathy, and estimated glomerular filtration rate were the included variables.
14 Dec 2018

No link between vitamin D, omega-3 fatty acid supplements and improved kidney function

An ancillary analysis of the Vitamin D and Omega-3 Trial (VITAL) included 1,312 adult patients with type 2 diabetes who agreed to additional testing of kidney function and urinary albumin excretion at baseline and two and five years after randomization.
13 Dec 2019

Mortality benefit of tighter glycemic control may vary by diabetes duration, study finds

Mortality risk increased with worse glycemic control among patients who had had diabetes for less than five years, while a mean HbA1c level between 6.5% to 7.9% was associated with the lowest mortality risk in those who had had the disease longer.
8 Nov 2019

Incretin-based drugs not associated with any increase in risk for pancreatic diseases

The findings may reassure prescribers of dipeptidyl peptidase-4 inhibitors that the drug class does not significantly increase the risk of adverse pancreatic outcomes compared with other second-line therapies, study authors said.
9 Nov 2018

Spotlight on depression in diabetes

Recent studies analyzed depression in diabetes, including associated causes of death, the potential benefits of peer support and a plant-based diet, and strategies for screening and treatment.
9 Nov 2018

Metformin associated with fewer cardiovascular events than sulfonylureas after decline in kidney function

The findings from this retrospective study further support metformin as the first-line treatment to which other diabetes medications are added, even in patients who are in the early stages of chronic kidney disease, an editorial noted.
11 Oct 2019

Result Page: Prev   12   13   14   15   16   17   18   19   20   21   Next